Volume 19 Issue 4
Apr.  2021
Turn off MathJax
Article Contents
Article Navigation >  Chinese Journal of General Practice  > 2021  >  19(4): 554-557,576
Ll Ying, YANG Bo, ZHANG Jing. The prognostic value of SII, NLR, PLR and LMR in the stage of ⅠA-ⅡA2 cervical cancer[J]. Chinese Journal of General Practice, 2021, 19(4): 554-557,576. doi: 10.16766/j.cnki.issn.1674-4152.001859
Citation: Ll Ying, YANG Bo, ZHANG Jing. The prognostic value of SII, NLR, PLR and LMR in the stage of ⅠA-ⅡA2 cervical cancer[J]. Chinese Journal of General Practice, 2021, 19(4): 554-557,576. doi: 10.16766/j.cnki.issn.1674-4152.001859
shu

The prognostic value of SII, NLR, PLR and LMR in the stage of ⅠA-ⅡA2 cervical cancer

doi: 10.16766/j.cnki.issn.1674-4152.001859

  • Department of Oncology, the First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233004, China

Funds:

 KJ2019A0384

  • Received Date: 2020-12-10
    Available Online: 2022-02-16
    Abstract
  •   Objective  To investigate the prognostic value of systemic immune inflammatory index (SⅡ), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), and lymphocyte to monocyte ratio (LMR) in patients with cervical cancer of stage ⅠA-ⅡA2 before treatment.  Methods  196 patients with cervical cancer of stage ⅠA2-ⅡA2 who were initially diagnosed in the First Affiliated Hospital of Bengbu Medical College from May 2012 to December 2014 were included. The Cut off values of NLR, PLR, LMR and SⅡ were calculated and divided into high and low value groups.The relationship between the four indexes and clinicopathological parameters in the high and low value groups were observed. The difference in overall survival between high and low value groups were compared. Univariate and multivariate analyses were performed to assess the predictive validity of independent risk factors, and establish a nomogram.  Results  NLR was correlated with histological type and lymphatic vascular stromal infiltration, PLR was correlated with histological type and tumor size, and SⅡ was correlated with histological type, with statistically significant difference respectively (all P < 0.05). The high value group of NLR, PLR and SⅡ and the low value group of LMR had shorter OS, and the difference was statistically significant (all P < 0.05). PLR, SⅡ, histological type and lymph node metastasis were independent risk factors for OS (all P < 0.05). Predictive validity: PLR>SⅡ>lymph node metastasis>the histological type (AUC: 73.2%>71.9%>65.1%>37.0%). The accuracy of the nomogram was high (OS3/OS5 AUC: 90.7%/79.1%).  Conclusion  The value of PLR and SⅡ before treatment can be reliable indicators to predict the prognosis of patients with stage ⅠA2~ⅡA2 cervical cancer.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    WILD C P, WEⅡDERPASS E, STEWART B W. World cancer report: cancer research for cancer prevention[M]. Lyon: International Agency for Research on Cancer, 2020.
    [2]
    HUANG H, LIU Q, ZHU L, et al. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer[J]. Sci Rep, 2019, 9(1): 87-108. doi: 10.1038/s41598-018-36442-9
    [3]
    TEOH D G K, ISAKSSON V R, MONU M, et al. The predictive value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in determining cervical cancer stage[J]. Gynecol Oncol, 2017, 145(3): 83. http://www.sciencedirect.com/science?_ob=ShoppingCartURL&_method=add&_eid=1-s2.0-S0090825817304110&originContentFamily=serial&_origin=article&_ts=1498985259&md5=e0eb81f6f3ccd574b01e6afb6d084274
    [4]
    HAMILTON T, STEPHEN P D, JALAL H, et al. Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)[J]. Clinca Chimica Acta, 2020, 510(5): 711-716. http://www.sciencedirect.com/science/article/pii/S000989812030440X
    [5]
    周晖, 刘昀昀, 罗铭, 等. 《2020 NCCN子宫颈癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2020, 36(2): 131-138. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202002011.htm
    [6]
    解秀珍. ⅠB-ⅡA期宫颈癌患者宫旁组织浸润的相关因素及腺癌与鳞癌的预后比较[D]. 济南: 山东大学, 2017.
    [7]
    KAILASH N, MING Y L, SRINIVAS K-C, et al. Redistribution of cervix cancer patients from FIGO 2009 to FIGO 2018 staging following incorporation of medical imaging[J]. Int J Gynecol Cancer, 2019, 17(4): 1-8. http://www.researchgate.net/publication/336989640_Redistribution_of_Cervix_Cancer_Patients_from_FIGO_2009_to_FIGO_2018_Staging_Following_Incorporation_of_Medical_Imaging
    [8]
    RICHA S, MOHAMMAD A, VARSHA S, et al. M2 polarization of macrophages by Oncostatin M in hypoxic tumor microenvironment is mediated by mTORC2 and promotes tumor growth and metastasis[J]. Cytokine, 2019, 118(6): 130-143. http://www.sciencedirect.com/science?_ob=ShoppingCartURL&_method=add&_eid=1-s2.0-S1043466618301182&originContentFamily=serial&_origin=article&_ts=1522773976&md5=5b2cc6f4c76375a499cc5439562552d4
    [9]
    VITKAUSKAITE A, URBONIENE D, CELIESITUE J, et al. Circulating inflammatory markers in cervical cancer patients and healthy controls[J]. J Immunotoxicol, 2020, 17(1): 105-109. doi: 10.1080/1547691X.2020.1755397
    [10]
    王金凤, 李琛, 黄康榕, 等. 术前中性粒细胞和淋巴细胞比值、单核细胞和淋巴细胞比值与宫颈癌患者临床病理特征的相关性[J]. 兰州大学学报(医学版), 2019, 45(5): 25-29. https://www.cnki.com.cn/Article/CJFDTOTAL-LZYX201905008.htm
    [11]
    YUDA P, AGHA B, FIRDY L, et al. Pretreament neutrophi-to-lymphocyte ratio(NLR) and platelt-to-lymphocyte ratio(PLR) as a predicitive value of hematological markers in cervical cancer[J]. Asian Pac J Cancer Prew, 2019, 20(3), 863-868. doi: 10.31557/APJCP.2019.20.3.863
    [12]
    ZHU M, FENG M, HE F, et al. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer[J]. Clinica Chimica Acta, 2018, 483(5): 296-302.
    [13]
    CHEN L, ZHANG F, SHENG X, et al. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: lymphocyte[J]. Medicine, 2016, 95(32): e4381. doi: 10.1097/MD.0000000000004381
    [14]
    JI Y F, WANG H Y. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis[J]. World J Surg Oncol, 2020, 18(1): 847-860. http://www.researchgate.net/publication/343520941_Prognostic_prediction_of_systemic_immune-inflammation_index_for_patients_with_gynecological_and_breast_cancers_a_meta-analysis/download
    [15]
    GAO Y, GUO W, CAI S, et al. Systemic immune-inflammation index (SⅡ) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma[J]. J Cancer, 2019, 10(14): 3188-3196. doi: 10.7150/jca.30281
    [16]
    CHAO B, JU X, ZHANG L, et al. A novel prognostic marker systemic inflammation response index (SIRI) for operable cervical cancer patients[J]. Front Oncol, 2020, 10(1): 766. http://www.researchgate.net/publication/341348990_A_Novel_Prognostic_Marker_Systemic_Inflammation_Response_Index_SIRI_for_Operable_Cervical_Cancer_Patients
    [17]
    HOLUB K, BIETE A. Impact of systemic inlammation biomarkers on the survival outcomes of cervical cancer patients[J]. Clin Transl Oncol, 2019, 21(7): 836-844. doi: 10.1007/s12094-018-1991-4
    [18]
    WU J, CHEN M, LIANG C, et al. Prognostic value of the pretreament neutrophi-to-lymphocyte ratio in cervical cancer: A meta-analysis and systematic review[J]. Oncotarget, 2017, 8(8): 13400-13412. doi: 10.18632/oncotarget.14541
    [19]
    KOZASA K, MABUCHI S, KOMURA N, et al. Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review[J]. Oncotarget, 2017, 8(33): 55394-55404. doi: 10.18632/oncotarget.19560
    [20]
    Paul D S, Trinh H, Hyder J, et al. Prognostic value of changes in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) for patients with cervical cancer undergoing definitive chemoradiotherapy (dCRT)[J] Clinica Chimica Acta, 2020, 510(11): 711-716. http://www.sciencedirect.com/science/article/pii/S000989812030440X
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (352) PDF downloads(9) Cited by()
    Proportional views
    Related

    Address：No. 287, Changhuai Road, Bengbu, Anhui Province, 233004, P.R.ChinaphoneNo：0552-3066635； 0552-3051890Email：zhqkyx@163.com

    Copyright © Chinese Journal of General Practice皖ICP备2020018345号-2

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return